The APC-bioengineered scaffolds showed a BAX/BCL2 ratio superior to 2D control counterparts, but the difference did not reach statistical significance (PCL: 2.48 ± 0.58-fold change vs. 2D; PLGA: 1.47 ± 0.19-fold change vs. 2D).
← all excerpts
Fabrication of New Hybrid Scaffolds for <i>in vivo</i> Perivascular Application to Treat Limb Ischemia.
1
—
—